BRAF p. V600E Mutation as Acquired Resistance Mechanism of Lorlatinib in a ROS1 Rearrangement Lung Adenocarcinoma Patient with Liver Metastasis with Primary Ceritinib Resistance
Japanese Journal of Gastroenterology and Hepatology（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要